Please assess the completion status of the following clinical trial:

Trial Title: Intramuscular Injections of Botulinum Toxin in Lateral Pterygoid Muscle in the Treatment of Temporomandibular Dysfunctions: Studying the Interest of MRI Guidance and Ultrasound Guidance

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* patients suffering from muscular TemporoMandibular Dysfunctions (TMD) with clinical diagnosis: myofascial pain, limited opening of the mouth, articular noise.~* \>= 18 years old~* with signed informed consent form~Exclusion Criteria:~* articular TMD: arthritis or other inflammatory disease of temporomandibular joint, arthrosis, bone deformation, previous fracture of condylar area ;~* electromyographic hypoactivity, pure muscular diseases ;~* oro-mandibular dystonia ;~* botulinum toxin allergy,~* risk of bleeding~* recent or active infection~* intercurrent antibiotic treatment (drug interaction) ;~* vaccination during the 15 days preceding the injection.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- MRI guidance (Type: EXPERIMENTAL): Injections of botulinum toxin performed using MRI guidance
- Ultrasound guidance (Type: EXPERIMENTAL): Injections of botulinum toxin performed using ultrasound guidance

Based on this trial design, predict the completion outcome and termination type (if applicable).